None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) 20 years of age or older among patients with irritable bowel syndrome who satisfy Rome IV a person under 75 years of age ; Patients falling under ? and ?, including at least two of ? ? ? If abdominal pain and abdominal discomfort persist for more than two days a month in the last three months ? If abdominal pain has been repeated for more than one day a week in the last three months ? If you have discomfort related to defecation ? If there is a change in the frequency of feces (increasing or decreasing) ? If there is a change in the shape of the stool (appearance) ? Symptoms started at least six months ago, and if it falls under ? or ? 2) Those whose weekly average of the most severe abdominal pain in the last 7 days is 3 or higher on a scale of 0 to 10 3) A person who has experienced at least one type 6 or 7 diarrhea-type stool according to the Bristol Stool Form Scale/BSFS2) in the last 7 days for at least 2 days 4) A person who does not have a matrix lesion in the large intestine in barium colonography or colonoscopy performed within the last 5 years 5) A person who has consented in writing to this clinical trial and is deemed competent to conduct this study
Exclusion criteria
Exclusion criteria: 1) Patients who have undergone gastrointestinal surgery (except appendectomy and hernia surgery) 2) If a disease (e.g., an organic disease such as colitis or colorectal cancer) is present or has been within the past two years that may affect the evaluation of the effectiveness of digestive system drugs 3) an antithrombotic/blood coagulant 4) a cardiovascular patient 5) Serious internal medical conditions (e.g., liver cancer or cirrhosis, chronic renal failure, heart failure, thyroid disease) are accompanied 6) Pregnant and lactating women or women of childbearing age who do not use appropriate contraception 7) A person who participated in a clinical study related to acupuncture within the last 6 months 8) A person with skin allergies or skin ulcers or skin infections related to saliva 9) Other patients found difficult to participate in this clinical trial by the tester
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritable Bowl Syndrome-Symptom Severity Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Bristol stool scale;EQ-5D-5L;Patient Global Assessment;collection of human-derived materials | — |
Countries
Korea, Republic of
Contacts
Dongshin University